WebWe also observed opsin expression in some supporting cells and in vestibular ganglion. Two control mice injected with saline ( Figure 2 D) and two wild-type non-injected mice (Figures 4A and 4B ... WebOur results demonstrate that Chronos has the ability to drive the auditory system at higher stimulation rates than ChR2 and may be a more ideal opsin for manipulation of auditory pathways in future optogenetic-based neuroprostheses. This article is part of a Special Issue entitled "Lasker Award".
Histologic Analysis of Chronos in an Optogenetics-Based …
WebScale bar 5 μm. (B) Membrane resistance was not affected by opsin expression (mean ± SD, across cells). (C) Resting membrane potential was similar between opsin-expressing and control neurons (mean ± SD). ... Chronos photocurrents had the fastest deactivation time constant, while CoChR and ChrimsonR showed similar deactivation kinetics (mean ... WebNov 1, 2024 · Here, we show that exciting the fast opsin Chronos with amplified laser 2P-CGH enables cellular-resolution targeting with unprecedented temporal control, driving spiking up to 100 Hz with … section 172 1 strategic report
National Center for Biotechnology Information
WebTo compare the magnitude of the optogenetically-induced EPSCs between control and KD neurons, you can sparsely label the opsin and record the EPSCs from both types of neurons in the same slices by ... WebApr 1, 2015 · The cochlear implant (CI) is the most successful of neuroprostheses, and provides meaningful auditory benefits to pediatric and adult patients with severe to profound hearing loss. In the past 50 years, over 300,000 individuals worldwide have received a CI ( NIDCD, 2014 ). WebApr 19, 2024 · We light-activated nigral terminals expressing Chronos opsin in the SC while recording from visually identified PDB neurons (Figures 3A 1–3 and S2). Optogenetic stimulation of nigral neurons expressing Chronos increased their spike frequency above spontaneous levels, thus mimicking increases in the nigro-collicular inhibitory drive … section 1725 of title 38